CD44 and colorectal carcinoma: Given their importance, a sea of biomarkers characterizing CSCs (e.g., CD44, CD166, EpCAM, Oct‐3/4) have been established and linked to CRC diagnosis, treatment, and prognosis.166, 167, 168